Workflow
机构风向标 | 迈克生物(300463)2025年二季度已披露持仓机构仅4家

Core Insights - On August 1, 2025, Mike Biotech (300463.SZ) released its semi-annual report for 2025, indicating a total of 20.3664 million shares held by institutional investors, accounting for 3.33% of the total share capital [1] - The proportion of shares held by institutional investors decreased by 0.82 percentage points compared to the previous quarter [1] Institutional Holdings - Four institutional investors disclosed their holdings in Mike Biotech, including Shanghai Axiang Investment Management Co., Ltd., Hong Kong Central Clearing Limited, Xinhua Pension Tonghai Stable Progress No. 2 Stock-type Pension Product, and CITIC Securities Asset Management (Hong Kong) Co., Ltd. [1] - The total institutional holding ratio stands at 3.33% [1] Public Fund and Foreign Investment - One public fund, ICBC CSI 500 Six-Month Holding Index Enhanced A, was not disclosed in the current period compared to the previous quarter [1] - Foreign investment sentiment showed a decrease, with one foreign fund, Hong Kong Central Clearing Limited, reducing its holdings by 1.43% compared to the previous quarter [1]